Production (Stage)
Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.09
-$0.15-12.10%
OTC PK
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 76.83M | 76.83M | 63.77M |
| Total Depreciation and Amortization | -- | -- | 14.43M | 14.43M | 14.42M |
| Total Amortization of Deferred Charges | -- | -- | 885.70K | 885.70K | 885.70K |
| Total Other Non-Cash Items | -- | -- | 50.26M | 50.26M | 33.11M |
| Change in Net Operating Assets | -- | -- | -40.38M | -40.38M | -8.76M |
| Cash from Operations | -- | -- | 102.03M | 102.03M | 103.43M |
| Capital Expenditure | -- | -- | -10.29M | -10.29M | -11.94M |
| Sale of Property, Plant, and Equipment | -- | -- | 636.00K | 636.00K | 769.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -12.15M | -12.15M | -4.83M |
| Cash from Investing | -- | -- | -21.80M | -21.80M | -15.99M |
| Total Debt Issued | -- | -- | 4.05B | 4.05B | 5.59B |
| Total Debt Repaid | -- | -- | -4.01B | -4.01B | -5.42B |
| Issuance of Common Stock | -- | -- | 1.86B | 1.86B | 1.79B |
| Repurchase of Common Stock | -- | -- | -1.89B | -1.89B | -1.96B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -45.73M | -45.73M | -44.64M |
| Other Financing Activities | -- | -- | -820.09M | -820.09M | -822.85M |
| Cash from Financing | -- | -- | -92.62M | -92.62M | -91.66M |
| Foreign Exchange rate Adjustments | -- | -- | 4.79M | 4.79M | -430.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -7.60M | -7.60M | -4.66M |